mRNA |
XL-184 |
GDSC1000 |
pan-cancer |
AAC |
-0.038 |
0.2 |
mRNA |
PDMP |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.2 |
mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
BRD-K27224038 |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.3 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.3 |
mRNA |
BRD-K29086754 |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.3 |
mRNA |
spautin-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.3 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.3 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.3 |
mRNA |
Nilotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.04 |
0.3 |